Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Chemotherapy Prior to Reduced Intensity Conditioning: Interventional Study in Haploidentical Hematopoietic Stem Cells Transplantation for Patients With Refractory Acute Myeloid Leukemia

NCT03035422 is registered in ClinicalTrials.gov with Association for Training, Education, and Research in Hematology, Immunology, and Transplantation as lead sponsor.

NCT NCT03035422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03035422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Chemotherapy Prior to Reduced Intensity Conditioning: Interventional Study in Haploidentical Hematopoietic Stem Cells Transplantation for Patients With Refractory Acute Myeloid Leukemia
Lead sponsor
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2018
Completion date
December 18, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory acute myeloid leukemia